Perrigo Co. Plc (PRGO)
15.38
-0.08
(-0.49%)
USD |
NYSE |
Oct 13, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
Perrigo Shareholders Equity (Quarterly) : 2.516B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.516B |
| March 31, 2026 | 2.499B |
| December 31, 2025 | 2.936B |
| September 30, 2025 | 4.446B |
| June 30, 2025 | 4.472B |
| March 31, 2025 | 4.364B |
| December 31, 2024 | 4.319B |
| September 30, 2024 | 4.566B |
| June 30, 2024 | 4.545B |
| March 31, 2024 | 4.687B |
| December 31, 2023 | 4.768B |
| September 30, 2023 | 4.738B |
| June 30, 2023 | 4.849B |
| March 31, 2023 | 4.834B |
| December 31, 2022 | 4.842B |
| September 30, 2022 | 4.603B |
| June 30, 2022 | 4.850B |
| March 31, 2022 | 5.104B |
| December 31, 2021 | 5.152B |
| September 30, 2021 | 5.182B |
| June 30, 2021 | 5.511B |
| March 31, 2021 | 5.558B |
| December 31, 2020 | 5.655B |
| September 30, 2020 | 5.820B |
| June 30, 2020 | 5.910B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.786B |
| December 31, 2019 | 5.804B |
| September 30, 2019 | 5.759B |
| June 30, 2019 | 5.726B |
| March 31, 2019 | 5.701B |
| December 31, 2018 | 5.668B |
| September 30, 2018 | 5.660B |
| June 30, 2018 | 5.897B |
| March 31, 2018 | 6.205B |
| December 31, 2017 | 6.170B |
| September 30, 2017 | 6.042B |
| June 30, 2017 | 6.081B |
| March 31, 2017 | 6.068B |
| December 31, 2016 | 5.958B |
| September 30, 2016 | 7.483B |
| June 30, 2016 | 9.049B |
| March 31, 2016 | 9.726B |
| December 31, 2015 | 10.04B |
| September 30, 2015 | 10.73B |
| June 30, 2015 | 10.66B |
| March 31, 2015 | 9.586B |
| June 30, 2014 | 8.693B |
| March 31, 2014 | 8.558B |
| December 31, 2013 | 8.500B |
| September 30, 2013 | 2.469B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.610B |
| Total Liabilities (Quarterly) | 5.094B |
| Debt to Equity Ratio | 1.375 |
| Current Ratio | 2.324 |
| Net Debt Paydown Yield | 4.80% |